Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

The search for a cure news

Show

From To
Experimental HIV therapy may block virus longer with fewer drugs, Florida study says

A new therapy for HIV that does not require a lifelong regimen of daily drug cocktails may be on the horizon if early indications from studies on mice prove effective in people, scientists at the Scripps Research Institute in Florida announced Tuesday in the journal, Cell Reports.

Published
18 October 2017
From
Miami Herald
Gilead Awards $7.5 Million in Second Round of Grants to Advance HIV Cure Research

Gilead Sciences, Inc. today announced the second round of recipients of its HIV cure grants program. This new commitment will provide $7.5 million to support five additional HIV cure research initiatives led by top academic institutions and focused on translational research and efficacy studies in preclinical models.

Published
16 October 2017
From
Gilead press release
HIV controlled with improved CAR T therapy; human testing planned next spring

A breakthrough cancer treatment is to be tested in patients next year for its original purpose, controlling HIV infection.

Published
13 October 2017
From
The San Diego Union-Tribune
New approach for AIDS: Lock HIV in reservoir cells, to die through apoptosis

With the successful suppression of the AIDS virus (HIV) through medication, the focus turns toward its eradication. Researchers have developed a new compound that is key to the destruction of HIV. When the compound is introduced into infected cells, viral budding is suppressed thereby confining it within the host cells. The cell then dies naturally through apoptosis. This treatment is hoped to lead to the complete recovery from AIDS in the near future.

Published
04 October 2017
From
Science Daily
Progress in fighting HIV 'could save lung cancer victims too'

Cancer Research UK has awarded two London experts, Professor Charles Swanton and Dr Jonathan Hare, £250,000 to study whether similarities in the way the Aids virus and lung cancer evade the immune system could lead to the first improvement in survival rates in the latter in two decades.

Published
02 October 2017
From
Evening Standard
UNC researchers identify a new HIV reservoir

"The fact that HIV-infected macrophages can persist means that any possible therapeutic intervention to eradicate HIV might have to target two very different types of cells."

Published
25 September 2017
From
UNC press release
How do we know if someone’s in HIV remission?

One of the challenges in the field of HIV cure and remission is that researchers are not able to predict what will happen when a person living with HIV stops HIV medications.

Published
25 September 2017
From
BETA blog
Is It Ethical to Take People Off HIV Meds for Cure Research?

Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.

Published
13 September 2017
From
Poz
HIV Survivors Give Their 'Last Gift' In A New San Diego Study

The Last Gift study at UC San Diego is a unique new research effort focusing on HIV patients with a terminal illness such as cancer, ALS or advanced heart disease. Participants must have a prognosis of less than six months to live. When they near the end of their lives, they stop taking their HIV medications and let researchers draw blood regularly to monitor the activity of the virus. They also consent to having their bodies autopsied within hours of death.

Published
11 September 2017
From
KPBS
Looking for 'a multitude of ways to cure HIV'

HIV researchers draw hope from cancer immunotherapies — and inspiration from Timothy Ray Brown

Published
22 August 2017
From
Fred Hutch News Service
← First12345...44Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.